An international team led by researchers at Lund University in Sweden has identified the molecular tools needed to reprogram ordinary cells into specialized immune cells. The discovery, published in ...

From the discovery of the Yamanaka factors to late-stage clinical trials, induced pluripotent stem cells have revolutionized biomedical science. For the first time, scientists reprogrammed cells from ...

iXCells’ mission is to empower life science researchers and patient foundations to advance personalized therapies and accelerate discovery of better medicines for a healthier future. iXCells’ cell ...

Research led by Naval Medical University's Changzheng Hospital in China reports that an off-the-shelf cell therapy built from induced pluripotent stem cells (iPSCs) loosened life-limiting skin and ...

Human induced pluripotent stem cell (iPSC) technology has enabled the generation of virtually any human cell type from somatic cells obtained from healthy or disease donors. This powerful platform has ...

The New York Blood Center Enterprises and the Chan Zuckerberg Biohub are collaborating to derive induced pluripotent stem cell lines from cord blood, using NYBCe’s inventory of over 30,000 units, ...

Efficient T-cell engineering is crucial for the success of CAR T-cell therapy research, but it requires multiple labor-intensive steps, including T-cell isolation, activation, and transduction.

Preclinical study showed iRECs Integrated into host vascular network and revascularized the ischemic eye, rescuing the tissue.

In the study, "An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis," published in Cell, researchers engineered an allogeneic cell therapy, QN-139b, to deplete pathogenic B ...